The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab
about
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab
description
im November 2015 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 November 2015
@en
name
The presence of genomic imbala ...... emotherapy including rituximab
@en
type
label
The presence of genomic imbala ...... emotherapy including rituximab
@en
prefLabel
The presence of genomic imbala ...... emotherapy including rituximab
@en
P2093
P50
P356
P1476
The presence of genomic imbala ...... emotherapy including rituximab
@en
P2093
Alfonso García de Coca
Carlos Grande
Carmen Olivier
Estrella Carrillo
Javier Menárguez
Jesús M Hernández-Sánchez
Jordi Ribera
Josep-María Ribera
Lourdes Escoda
María Hernández-Sánchez
P304
P356
10.1111/BJH.13849
P50
P577
2015-11-16T00:00:00Z